Wednesday, November 19, 2008
Lumen device gets FDA approval
Minneapolis / St. Paul Business Journal - by Katharine Grayson Staff Writer
Lumen Biomedical Inc. said Wednesday it has received regulatory approval to market a device used to treat artery disease.
The company’s product, dubbed FiberNet, is used to filter out debris following treatments in blood vessels. Such debris can increase a patient’s risk of suffering a stroke.
Plymouth-based Lumen develops medical devices. Earlier this year, the U.S. Food and Drug Administration approved its FiberNet device to be used in peripheral arteries.
Lumen’s backers include St. Jude Medical Inc., which put $13 million into the smaller company in 2006. Lumen was launched by Matthew Ogle, a former St. Jude scientist.
kgrayson@bizjournals.com | (612) 288-2106
Latest News |
